DNA Script

Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)

Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. DNA Script is based in Paris, France and was founded in 2014. It was valued at $660 million at its later-stage round in Jan 2022, the last priced event on record. It has raised $299 million across 1 recorded round; the latest was a $192 million Series C in Jan 2022.

PMV mark · valuation
$659.7M
Oct 2026
Priced at
its later-stage round
Jan 2022
Total raised
$298.7M
Last round
Later Stage VC (Series C)
Jan 2022

Who backs DNA Script?

34 investors
InvestorType
BpifranceOther
Fidelity Management & Research CompanyAsset manager
European CommissionOther
Coatue ManagementPE / buyout
La French TechOther
Alexandria Venture InvestmentsOther
AgoranovOther
Baillie GiffordGrowth equity
Catalio Capital ManagementVenture capital
Sofinnova PartnersVenture capital
+ 24 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

DNA Script investors

34 investors are on record for DNA Script, including Bpifrance, Fidelity Management & Research Company, European Commission and Coatue Management. By type, the record holds 8 venture capital firms and 4 hedge funds. The Series C in Jan 2022 drew 20 investors.

Free account
More of DNA Script with a free account
  • ·The complete investor list: 34 names
  • ·Watch DNA Script: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 34 firms already write checks for companies like DNA Script in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View